Literature DB >> 12325048

Thinking preventively about dementia: a review.

Brian Cooper1.   

Abstract

BACKGROUND: The dementias of late life now constitute a major public health challenge to our society.
OBJECTIVE: To examine the contributions of neuroscience, clinical treatment and health-care policy to the building of a national programme for preventive approaches to dementia.
METHOD: Critical review of the literature, making use of international databases (Medline, Embase, Psychlit) and British official publications.
RESULTS: Recent developments in a number of research fields afford prospects for advances in primary and secondary prevention. These include findings from case-control and cohort studies of associations with earlier head injury and vascular disease, possibilities of pharmacological protection for persons at high risk for Alzheimer's disease, and the use of more effective anti-dementia drugs in the mild to moderate stages of severity. Research aimed at tertiary prevention is lagging behind, but there are some indications that the worst features of late-stage decline could already be mitigated by improvements in community support services and nursing-home care.
CONCLUSIONS: Containment of the growing social and economic burdens of dementia calls for a national policy to ensure that new research findings can be translated into practice and applied to the benefit of all old people who stand in need. For this purpose the most appropriate conceptual framework is supplied by a preventive model, broadly similar to those already developed for some other forms of chronic degenerative disease. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12325048     DOI: 10.1002/gps.707

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  1 in total

1.  Predictive diagnostics and personalized medicine for the prevention of chronic degenerative diseases.

Authors:  Federico Licastro; Calogero Caruso
Journal:  Immun Ageing       Date:  2010-12-16       Impact factor: 6.400

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.